Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide Tirzepatide is a dual GIP and GLP-1 receptor agonist used to treat type II diabetes in adults as an adjunct to diet and exercise
It does this partly by upregulating the genes responsible for extracellular matrix proteins and partly by increasing the production of glycosaminoglycans (GAGs) the ground substance that supports the collagen network [1]
Pros Rapid delivery into the body
The field requires urgent Phase I/II human trials before any clinical recommendations can be made
Still, the lack of long term data means no peptide is completely risk-free
References to the recent vote of the Committee are based on publicly available information
